Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer
NCT05318794
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Peritoneal Metastases
Chemotherapy Effect
Interventions
DRUG:
Doxorubicin and Cisplatin
Sponsor
Imperial College London